Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds
NDTV Profit

Analysts estimate the pharmaceutical company's consolidated revenue to rise just 0.6% year on year.
Summary from NDTV Profit
Read the full story on NDTV Profit
Analysts estimate the pharmaceutical company's consolidated revenue to rise just 0.6% year on year.
Summary from NDTV Profit
Read the full story on NDTV Profit






